Related Experiment Video
Updated: Jan 9, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Cefepime-Induced Neurotoxicity in an Elderly Patient: A Case Report
Miguel Herrera1, Carlos F Caballero1, Brian J Robles1
1Internal Medicine, Hospital Gustavo Nelson Collado, Chitre, PAN.
None:
Cefepime, a fourth-generation cephalosporin, may cause neurotoxicity, especially in patients with renal impairment. We report an 81-year-old man with chronic kidney disease (CKD) treated with intravenous cefepime for pneumonia. After five days, he developed acute confusion and reduced consciousness. Laboratory results showed no metabolic abnormalities and no microbial growth in blood cultures, and chest X-ray images improved. Cefepime-induced neurotoxicity (CIN) was suspected; the drug was discontinued and replaced with piperacillin-tazobactam. Neurological status recovered fully within 48 hours. This case underscores the need to recognize cefepime neurotoxicity in elderly patients with renal dysfunction, ensuring timely intervention through dose adjustment or discontinuation.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
